Mr. Syed Luqman Ali | Drug Design | Best Researcher Award
Researcher, Abdul Wali Khan University Mardan KPK Pakistan, Pakistan
Mr. Syed Luqman Ali is an enthusiastic researcher specializing in bioinformatics, computational biology, vaccine design, cancer, and drug development. Currently pursuing an MPhil in Biochemistry at Abdul Wali Khan University Mardan (2025), he has published extensively on vaccine and drug design using advanced computational techniques like RNA-seq, molecular docking, and simulation. Mr. Ali is a skilled reviewer for several high-impact journals and a lecturer at Metanoia College of Nursing. With expertise in bioinformatics tools and programming languages, he is committed to advancing scientific knowledge in vaccine and drug research.
Publication Profile
Education
Mr. Syed Luqman Ali is currently pursuing his MPhil in Biochemistry at Abdul Wali Khan University Mardan, Pakistan, with an expected graduation in 2025. He completed his Bachelorβs degree in Biochemistry from the same institution in 2022, laying the foundation for his research career. Additionally, he holds a Diploma in Digital Information Technology from the Board of Technical Education Peshawar, Pakistan, earned in 2021. This diverse educational background has equipped him with a strong interdisciplinary skill set, combining biochemistry, digital technology, and computational biology for cutting-edge research.
Research Experience
Mr. Syed Luqman Ali has been an Experimental and Computational Researcher at Abdul Wali Khan University Mardan since 2019. His research focuses on vaccine and drug design, utilizing advanced computational techniques like RNA-seq analysis, molecular docking, and simulation. With extensive experience in leading bioinformatics databases such as KEGG, MetaCyc, and HADDOCK, Mr. Ali is proficient in tools like SnapGene, Cytoscape, and DAVID. His work contributes to the development of innovative vaccines and drug therapies, advancing scientific knowledge in bioinformatics and computational biology.
Technical Certifications
Mr. Syed Luqman Ali has acquired several technical certifications that complement his research expertise. He completed a Data Analysis with R program through Mindluster, enhancing his data analysis skills. Additionally, he has obtained certifications in Data Analysis with Python and Linux from Udemy, further strengthening his computational abilities. Mr. Ali also completed a Content Writing course through the DigiSkills Training Program from Virtual University, Lahore, improving his communication and writing skills for scientific documentation. These certifications underscore his commitment to continuous learning and professional development in bioinformatics and computational biology.
Awards and Achievements
Mr. Syed Luqman Ali has made significant contributions to the scientific community, with multiple publications in high-impact journals, showcasing his research prowess in bioinformatics and computational biology. His work has been recognized by peers and researchers worldwide. Additionally, Mr. Ali serves as a reviewer for several reputed scientific journals, contributing his expertise to the advancement of research. These achievements reflect his dedication to scientific excellence and his active role in shaping future advancements in his field. 
Mr. Syed Luqman Aliβs research spans multiple bioinformatics and computational biology domains, particularly in vaccine and drug design, cancer immunology, and genomics. His work includes multi-epitope vaccine development using immunoinformatics and reverse vaccinology approaches, along with genomic annotation for vaccine target identification. He has contributed significantly to disease diagnostics and drug discovery, especially in areas like tuberculosis, SARS-CoV-2, Leishmania, and autoimmune disorders. His expertise also extends to advanced data analysis, molecular docking, and RNA-seq analysis, employing tools like KEGG, MetaCyc, and HADDOCK. 
Publication Top Notes
- Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
Cited by: 20
Year: 2023 - Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica β a hierarchical subtractive proteomics and β¦
Cited by: 15
Year: 2023 - Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome β¦
Cited by: 12
Year: 2023 - Currently trending and futuristic biological modalities in the management of different types of diabetes: A comprehensive review
Cited by: 9
Year: 2023 - Analysis of the capability of IgG antibodies and receptors with their relationships to food tolerance and autoimmune disorders
Cited by: 6
Year: 2023 - Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs
Cited by: 4
Year: 2023 - Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
Cited by: 1
Year: 2024 - Genetic identification and determination of parasites (Babesia, Leptospira and Toxoplasma Gondi) in wild rats
Cited by: 1
Year: 2024 - Placental histology for targeted risk assessment of recurrent spontaneous preterm birth
Cited by: 1
Year: 2024 - Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
Cited by: 1
Year: 2024 - Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
Cited by: 1
Year: 2024 - Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches
Cited by: 1
Year: 2025 - Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
Cited by: 1
Year: 2024 - A Comprehensive Methodological Review of Major Developments in Bioinformatics Pipelines for Transcriptomic Data Analysis
Cited by: β
Year: 2024
Mr. Aliβs solid academic background, innovative research contributions, advanced technical skills, and role as a mentor, he is undoubtedly a strong candidate for the Research for Best Researcher Award. His work in bioinformatics, drug design, vaccine development, and cancer research showcases his dedication to advancing scientific knowledge and making a global impact.
Professor Faisal T. Al-Akayleh, Ph.D. is a distinguished expert in pharmaceutics and pharmaceutical technology, serving as the Head of the Department of Pharmaceutics and Pharmaceutical Technology at the University of Petra, Amman, Jordan. With a robust academic and professional background, Professor Al-Akayleh has made remarkable contributions as a pharmaceutical researcher, inventor, and consultant. He has authored five patents in the fields of nanotechnology, pharmaceutical science, and environmental applications. His innovative spirit is reflected in his leadership roles and impactful projects in drug delivery and nanotechnology. 
Ph.D. in Pharmaceutics and Pharmaceutical Technology β Professor Al-Akaylehβs academic journey is marked by his expertise in pharmaceutics, enabling him to advance the pharmaceutical industry with groundbreaking innovations. His education laid the foundation for his significant contributions to pharmaceutical technology and material science. 
With years of experience in academia and the pharmaceutical industry, Professor Al-Akayleh has served as a technical manager and consultant for various pharmaceutical companies. As an associate professor, he has led groundbreaking research projects and collaborated on numerous industry-funded initiatives. His leadership extends to his roles as a board member of the Jordan Journal of Pharmaceutical Sciences and the University of Petra Pharmaceutical Center. He also chairs the Ethical Approval Committee at the University of Petra. 
Professor Al-Akayleh received the prestigious El Hassan Bin Talal Award for Scientific Excellence (2018) for his collaborative project on developing an oral insulin delivery system. His dedication to innovation has garnered recognition for advancing pharmaceutical research and development. 
Professor Al-Akayleh specializes in drug delivery systems, nanotechnology, pharmaceutical material science, and environmental sustainability. His research addresses critical challenges in developing innovative drug formulations, including nanoparticles for improved skin permeation and novel excipients for enhanced drug delivery. 